Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
China · Delayed Price · Currency is CNY 10.01
+0.14 (1.42%)
Sep 1, 2026, 3:00 PM CST
SHA:603108 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,959 | 9,025 | 9,540 | 11,923 | 5,859 | 7,772 | |
Market Cap Growth | -43.82% | -5.40% | -19.99% | 103.50% | -24.61% | 19.95% |
Enterprise Value | 12,493 | 15,885 | 16,624 | 19,137 | 12,879 | 13,703 |
Last Close Price | 9.87 | 14.95 | 15.90 | 20.16 | 9.92 | 13.15 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 172.58 | 43.63 | 14.03 | 20.44 |
Forward PE | - | 90.61 | 21.33 | 21.20 | 13.66 | 15.50 |
PS Ratio | 0.89 | 1.29 | 1.15 | 1.30 | 0.56 | 0.88 |
PB Ratio | 1.27 | 1.85 | 1.70 | 2.19 | 1.17 | 1.77 |
P/TBV Ratio | 3.25 | 4.65 | 4.16 | 5.44 | 3.20 | 5.19 |
P/FCF Ratio | 12.50 | 23.34 | 22.84 | 29.09 | - | 110.98 |
P/OCF Ratio | 7.87 | 14.16 | 14.75 | 16.34 | - | 20.94 |
PEG Ratio | - | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.86 | 2.27 | 2.00 | 2.09 | 1.23 | 1.55 |
EV/EBITDA Ratio | 22.46 | 55.11 | 18.45 | 18.56 | 10.02 | 11.05 |
EV/EBIT Ratio | 64.00 | 9785.40 | 29.53 | 26.82 | 13.17 | 14.44 |
EV/FCF Ratio | 26.20 | 41.07 | 39.79 | 46.70 | - | 195.68 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.35 | 1.41 | 1.26 | 1.24 | 1.38 | 1.30 |
Debt / EBITDA Ratio | 11.36 | 20.11 | 7.36 | 6.20 | 5.06 | 4.34 |
Debt / FCF Ratio | 13.25 | 17.75 | 16.86 | 16.47 | - | 81.37 |
Net Debt / Equity Ratio | 1.18 | 1.17 | 1.03 | 1.03 | 1.15 | 1.06 |
Net Debt / EBITDA Ratio | 11.19 | 19.84 | 6.39 | 5.46 | 4.49 | 3.75 |
Net Debt / FCF Ratio | 11.61 | 14.79 | 13.78 | 13.72 | -8.24 | 66.39 |
Asset Turnover | 0.51 | 0.51 | 0.58 | 0.64 | 0.79 | 0.80 |
Inventory Turnover | 3.30 | 3.60 | 4.60 | 4.50 | 4.85 | 4.87 |
Quick Ratio | 0.73 | 0.77 | 0.91 | 0.93 | 0.87 | 0.90 |
Current Ratio | 1.07 | 1.11 | 1.22 | 1.25 | 1.15 | 1.20 |
Return on Equity (ROE) | -9.53% | -9.88% | 3.43% | 8.47% | 13.94% | 14.12% |
Return on Assets (ROA) | 0.92% | 0.01% | 2.46% | 3.09% | 4.61% | 5.35% |
Return on Invested Capital (ROIC) | 1.88% | 0.01% | 2.75% | 4.41% | 7.89% | 8.88% |
Return on Capital Employed (ROCE) | 3.70% | 0.00% | 8.30% | 10.50% | 16.30% | 16.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -8.65% | -6.08% | 0.58% | 2.29% | 7.13% | 4.89% |
FCF Yield | 8.00% | 4.29% | 4.38% | 3.44% | -11.96% | 0.90% |
Dividend Yield | 0.30% | - | 0.19% | 0.50% | 1.51% | - |
Payout Ratio | - | - | 610.24% | 138.14% | 58.45% | 71.74% |
Buyback Yield / Dilution | 2.88% | 1.89% | -5.63% | 2.56% | -0.45% | -2.63% |
Total Shareholder Return | 3.18% | 1.89% | -5.44% | 3.06% | 1.06% | -2.63% |